The story appears on

Page A11

October 22, 2021

GET this page in PDF

Free for subscribers

View shopping cart

Related News

HomeWorld

Nod for 鈥榤ix and match鈥 booster shots

The US Food and Drug Administration on Wednesday authorized using a so-called 鈥渕ix and match鈥 strategy for people who require a booster shot of a COVID-19 vaccine after their primary series.

鈥淭he FDA has determined that the known and potential benefits of the use of a single heterologous booster dose outweigh the known and potential risks of their use in eligible populations,鈥 the agency said in a statement.

The Pfizer, Moderna, and Johnson & Johnson vaccines are authorized in the United States. A single dose of any of them may now be used following completion of primary vaccination with a different COVID-19 vaccine.

According to the new decision, people who received two Moderna shots initially and are 65 years or older, over 18 years and at high risk for COVID-19, or over 18 and have high occupational exposure, may now receive a booster.

All adults who received the one-shot J&J vaccine more than two months ago are also eligible for a booster.

Previously, only immune compromised people or people who belonged to elderly or high risk groups and had received the Pfizer vaccine initially were eligible for a boost.

The data supporting the decisions come from research reviewed by the FDA.


 

Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

娌叕缃戝畨澶 31010602000204鍙

Email this to your friend